Nuclear Fusion, ISSN 0029-5515, 06/2017, Volume 57, Issue 10, p. 102001
The 2014-2016 JET results are reviewed in the light of their significance for optimising the ITER research plan for the active and non-active operation. More...
fusion | JET | ITER | plasma | COLLISIONALITY | DISRUPTION PREDICTION | ELMY H-MODES | PHYSICS, FLUIDS & PLASMAS | PEDESTAL | PLASMA-FACING COMPONENTS | OPERATION | CARBON WALL | DENSITY PEAKING | EDGE LOCALIZED MODES | DIAGNOSTICS | Mechanics | Engineering Sciences | Fluids mechanics | 70 PLASMA PHYSICS AND FUSION TECHNOLOGY | Fusion, Plasma and Space Physics | Fysik | Fusion, plasma och rymdfysik | Physical Sciences | Naturvetenskap | Natural Sciences
fusion | JET | ITER | plasma | COLLISIONALITY | DISRUPTION PREDICTION | ELMY H-MODES | PHYSICS, FLUIDS & PLASMAS | PEDESTAL | PLASMA-FACING COMPONENTS | OPERATION | CARBON WALL | DENSITY PEAKING | EDGE LOCALIZED MODES | DIAGNOSTICS | Mechanics | Engineering Sciences | Fluids mechanics | 70 PLASMA PHYSICS AND FUSION TECHNOLOGY | Fusion, Plasma and Space Physics | Fysik | Fusion, plasma och rymdfysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
Medical Oncology, ISSN 1357-0560, 8/2019, Volume 36, Issue 8, pp. 1 - 9
To evaluate the diagnostic performance of a whole-body 18F-choline (FCH) hybrid PET/MRI for prostate cancer patients at biochemical relapse after radical...
Pathology | Pelvic mpMRI | Medicine & Public Health | Hematology | Radical prostatectomy | Oncology | Internal Medicine | Prostate cancer | Biochemical recurrence | Whole-body FCH hybrid PET/MRI | Whole-body FCH hybrid PET | MRI | GUIDELINES | F-18-FLUOROCHOLINE PET/CT | PSA DOUBLING TIME | RELAPSE | C-11-CHOLINE PET/CT | LOCAL RECURRENCE | ONCOLOGY | EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY | SALVAGE RADIOTHERAPY | PROGRESSION | Pets | Relapse | Surgery | Choline | Metastasis | Diseases
Pathology | Pelvic mpMRI | Medicine & Public Health | Hematology | Radical prostatectomy | Oncology | Internal Medicine | Prostate cancer | Biochemical recurrence | Whole-body FCH hybrid PET/MRI | Whole-body FCH hybrid PET | MRI | GUIDELINES | F-18-FLUOROCHOLINE PET/CT | PSA DOUBLING TIME | RELAPSE | C-11-CHOLINE PET/CT | LOCAL RECURRENCE | ONCOLOGY | EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY | SALVAGE RADIOTHERAPY | PROGRESSION | Pets | Relapse | Surgery | Choline | Metastasis | Diseases
Journal Article
Oncotarget, ISSN 1949-2553, 09/2018, Volume 9, Issue 76, pp. 34196 - 34197
Journal Article
The Journal of Urology, ISSN 0022-5347, 08/2015, Volume 194, Issue 2, pp. 600 - 601
Journal Article
Nature Physics, ISSN 1745-2473, 10/2017, Volume 13, Issue 10, pp. 973 - 978
We describe a new technique for the efficient generation of high-energy ions with electromagnetic ion cyclotron waves in multi-ion plasmas. The discussed...
FUSION | PHYSICS, MULTIDISCIPLINARY | FREQUENCY | JET | HE-3-RICH SOLAR-FLARES | MODE CONVERSION | PHYSICS | CYCLOTRON RANGE | TOKAMAK | Deuterium | Plasma | Solar flares | Joint European Torus | Ions | Tokamak devices | Composition effects | Cyclotrons | Radio frequency | Toruses | Plasma composition | Heating | Energy efficiency | Plasmas | Plasma heating | Plasmas (physics) | Tècniques de plasma | Magnetically confined plasmas | Àrees temà tiques de la UPC | FÃsica | Plasma dynamics | Astrophysical plasmas | Physics | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
FUSION | PHYSICS, MULTIDISCIPLINARY | FREQUENCY | JET | HE-3-RICH SOLAR-FLARES | MODE CONVERSION | PHYSICS | CYCLOTRON RANGE | TOKAMAK | Deuterium | Plasma | Solar flares | Joint European Torus | Ions | Tokamak devices | Composition effects | Cyclotrons | Radio frequency | Toruses | Plasma composition | Heating | Energy efficiency | Plasmas | Plasma heating | Plasmas (physics) | Tècniques de plasma | Magnetically confined plasmas | Àrees temà tiques de la UPC | FÃsica | Plasma dynamics | Astrophysical plasmas | Physics | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
Journal of Urology, ISSN 0022-5347, 2015, Volume 194, Issue 2, pp. 600 - 601
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2016, Volume 6, p. 73
Salvage radiotherapy (SRT) represents the main treatment option for relapsing prostate cancer in patients after radical prostatectomy. Several open questions...
PSMA | Salvage radiotherapy | MRI | Prostate cancer | Choline | PET | prostate cancer
PSMA | Salvage radiotherapy | MRI | Prostate cancer | Choline | PET | prostate cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or...
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article